Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis

Ollech, JE; Normatov, I; Peleg, N; Dalal, SR; Pekow, J; Micic, D; Cohen, RD; Rubin, DT; Sakuraba, A

Ollech, JE (corresponding author), Univ Chicago Med, Inflammatory Bowel Dis Ctr, 5841 S Maryland Ave,MC 4076, Chicago, IL 60637 USA.; Ollech, JE (corresponding author), Rabin Med Ctr, Inflammatory Bowel Dis Ctr, Petah Tiqwa, Israel.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020; 35 (11): 2113

Abstract

Introduction In this study, we evaluate the efficacy and safety of the biosimilar infliximab, CT-P13, in the treatment of inpatients with severe stero......

Full Text Link